FDA approves Astellas' gastric cancer therapy
18/10/2024 17:24
Oct 18 (Reuters) - The U.S. Food and Drug Administration approved Astellas' 4503.T gastric cancer therapy, the health regulator's website showed on Friday. (Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsBrief: Immuneering To Collaborate With Astellas On Clinical Studies Of Investigational CLDN18.2 Programs In Combination With Atebimetinib For Pancreatic Cancer Patients
Health Rounds: New blood test finds early risk for ovarian cancer
Health Rounds: New blood test finds early risk for ovarian cancer
Refile: Astellas employee imprisoned in China to be released in December, Japanese media report
Table: Astellas Pharma -6-MTH group results (IFRS)